RET-IN-19
Product Specifications
CAS Number
2484919-71-1
Target
Others, c-RET, Aurora Kinase, c-Fms, MAPK, EGFR
Related Pathways
Chromatin/Epigenetic, Apoptosis, JAK/STAT signaling, Tyrosine Kinase/Adaptors, Others, MAPK, Angiogenesis, Cell Cycle/Checkpoint
Bioactivity
RET-IN-19 is a potent inhibitor of RET and exhibits anticancer effects on RET-wt (IC50: 6.8 nM) and RET V804M (IC50: 13.51 nM) .RET-IN-19 can be used to study non-small cell lung cancer (NSCLC) .
Smiles
N(C1=C2C(NC(=C2)C3=CC=C(S(C)(=O)=O)C=C3)=NC=N1)C4=CC=C(CC(NC=5C=C(C(C)(C)C)ON5)=O)C=C4
Molecular Formula
C28H28N6O4S
Molecular Weight
544.62
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV709335 1.0 µg DNA
DMC1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
abx496131-01 96 Tests
Human Suppression Of Tumorigenicity 14 (ST14) CLIA Kit
Sign In for Pricing
View Details abx496131-02 5x 96 Tests
Human Suppression Of Tumorigenicity 14 (ST14) CLIA Kit
Sign In for Pricing
View Details abx496131-03 10x 96 Tests
Human Suppression Of Tumorigenicity 14 (ST14) CLIA Kit
Sign In for Pricing
View Details